scispace - formally typeset
D

David A. Cooper

Researcher at Pfizer

Publications -  965
Citations -  81765

David A. Cooper is an academic researcher from Pfizer. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Viral load. The author has an hindex of 117, co-authored 903 publications receiving 69249 citations. Previous affiliations of David A. Cooper include Boston Children's Hospital & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Incidence and risk factors for human immunodeficiency virus seroconversion in a cohort of Sydney homosexual men.

TL;DR: Univariate analysis found that men who seroconverted were significantly more likely to have had a greater number of recent sexual partners, recent amphetamine abuse and a T‐suppressor‐cell count of greater than 800 cells/μL.
Journal Article

Culture and properties of cells derived from Kaposi sarcoma.

TL;DR: The establishment of four continuous cell cultures isolated from pleural or peritoneal fluid of patients with Kaposi sarcoma suggest that KS cells could sustain their own growth via an autocrine mechanism and support the existence of a paracrine pathway of EC proliferation in KS.
Journal ArticleDOI

Induction-maintenance antiretroviral therapy: proof of concept.

TL;DR: The potential for sustained antiviral response was explored for patients who began with ZDV-NVP-ddl and subsequently interrupted ddl in this article, where the authors investigated the concept of aggressive initial combination therapy followed by reduction to a less demanding maintenance regimen with respect to its potential for sustaining viral suppression.